China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
23.99
-0.93 (-3.73%)
Apr 28, 2026, 3:00 PM CST

SHA:600750 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,0594,2074,4044,5273,8462,856
Other Revenue
12.8412.8431.5126.2339.5817.88
4,0724,2204,4354,5533,8852,874
Revenue Growth (YoY)
-6.31%-4.87%-2.59%17.19%35.19%17.72%
Cost of Revenue
1,4121,4581,6341,6481,3841,026
Gross Profit
2,6602,7622,8012,9062,5011,848
Selling, General & Admin
1,4091,5261,7241,8621,7131,196
Research & Development
154.48152.79130.43141.4299.9787.82
Other Operating Expenses
68.1847.3641.5855.3559.3152.48
Operating Expenses
1,6291,7241,9042,0581,8741,336
Operating Income
1,0301,037897.39847.35626.7511.29
Interest Expense
-1.81-1.81-1.71-6.98-4.38-3.46
Interest & Investment Income
75.6275.7377.4868.793726.3
Other Non Operating Income (Expenses)
-5.840.517.57-2.29-12.33-8.77
EBT Excluding Unusual Items
1,0981,112990.74906.87646.99525.36
Gain (Loss) on Sale of Investments
0.590.59-11.46-40.0557.151.25
Gain (Loss) on Sale of Assets
0.610.611.841.22-0.130.9
Asset Writedown
14.13-0.68-1.05-2.04--
Other Unusual Items
100.52100.5245.5450.1249.3245.63
Pretax Income
1,2141,2131,026916.12753.28623.14
Income Tax Expense
221.41225.17165.11129.11106.8992.19
Earnings From Continuing Operations
992.81987.55860.51787.01646.39530.95
Net Income to Company
992.81987.55860.51787.01646.39530.95
Minority Interest in Earnings
-82.99-80.87-72.31-68.34-48.15-25.26
Net Income
909.82906.69788.19718.67598.24505.69
Net Income to Common
909.82906.69788.19718.67598.24505.69
Net Income Growth
13.15%15.03%9.67%20.13%18.30%6.74%
Shares Outstanding (Basic)
632634631719630632
Shares Outstanding (Diluted)
632634631719630632
Shares Change (YoY)
-0.02%0.55%-12.26%14.12%-0.38%0.07%
EPS (Basic)
1.441.431.251.000.950.80
EPS (Diluted)
1.441.431.251.000.950.80
EPS Growth
13.17%14.40%25.00%5.26%18.75%6.67%
Free Cash Flow
542.09690.29495.49828.31676.02728.55
Free Cash Flow Per Share
0.861.090.791.151.071.15
Dividend Per Share
1.3801.3801.2001.3001.1500.650
Dividend Growth
15.00%15.00%-7.69%13.04%76.92%140.74%
Gross Margin
65.33%65.45%63.16%63.81%64.37%64.29%
Operating Margin
25.31%24.58%20.23%18.61%16.13%17.79%
Profit Margin
22.35%21.49%17.77%15.78%15.40%17.59%
Free Cash Flow Margin
13.31%16.36%11.17%18.19%17.40%25.35%
EBITDA
1,1801,1841,033971.28746.78626.2
EBITDA Margin
28.98%28.06%23.28%21.33%19.22%21.79%
D&A For EBITDA
149.45146.62135.29123.94120.08114.91
EBIT
1,0301,037897.39847.35626.7511.29
EBIT Margin
25.31%24.58%20.23%18.61%16.13%17.79%
Effective Tax Rate
18.23%18.57%16.10%14.09%14.19%14.79%
Revenue as Reported
4,2204,2204,4354,5533,8852,874
Advertising Expenses
-385.39364.67404.92318.77321.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.